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Key Clinical Message
Explantation of an infected patent vascular graft does not necessarily require
concomitant revascularization procedures. The need for revascularization can
be determined by a trial cross-clamping of the graft and clinical assessment of
limb perfusion. We report a case of an infected axillofemoral graft transgressing
the chest wall in a surgically high risk patient.
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Introduction
Extra-anatomical revascularization for aortoiliac occlusive
disease is an effective alternative to limb amputation or
aortobifemoral bypass reserved for surgically high risk
patients and when previous endovascular recanalization
has failed or is contraindicated [1–3]. Axillofemoral
bypass grafts have improved since their emergence in
1963, with patency rates reasonable but inferior to aorto-
femoral and aortobifemoral grafts [1, 3]. Graft infection
and thrombosis can complicate axillofemoral bypasses,
with the subsequent management in surgically high risk
patients and hostile abdomens being difficult. We report
a rare case of an infected patent axillofemoral graft trans-
gressing the chest wall.
Case Report
A 96-year-old man presented to A&E unwell. His past
medical history was significant for frailty, COPD,
ischemic heart disease and multiple vascular operations
including a right axillofemoral bypass graft for occlusion
of a previous aorto-uni-iliac stent. On admission, he was
septic with a temperature of 38.6°C, heart rate of
118 bpm and a blood pressure of 179/80 mmHg. The
axillofemoral bypass graft was found to transgress the
right lateral chest wall with 10 cm of the graft external-
ized and exposed (Fig. 1). Purulent discharge and ery-
thema surrounded the site. On further questioning, the
graft had eroded through the skin several years prior with
no surgical advice sought. Both feet were warm and well
perfused. Femoral pulses only were palpable. His inflam-
matory markers were markedly elevated with a white cell
count of 217 9 109/L and CRP of 1814 mg/L. Proteus
mirabils and coagulase-negative staphylococcus were cul-
tured from the blood. A duplex ultrasound confirmed the
axillofemoral graft’s patency. CT angiography of the aorta
additionally demonstrated no significant graft enhance-
ment within the body (Fig. 2).
A diagnosis of graft related sepsis was made. He was
commenced on intravenous Pipercillin/Tazobactam as per
microbiological culture sensitivities. With overt clinical
and biochemical evidence of sepsis definitive treatment in
the form of graft explantation was required. In view of
the patient’s comorbidities and high anesthetic risk, sur-
gery was performed under local anesthesia. The axillofe-
moral graft was test-clamped for 30 min following
heparinization (5000 units). The leg was seen to remain
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viable allowing for the graft to be explanted without the
need for further revascularization. Proteus mirabils and
coagulase-negative staphylococcus were also cultured from
the graft confirming the diagnosis of graft sepsis. The
patient made an uncomplicated recovery with the leg
remaining neurovascularly intact. He was discharged
home on postoperative day 9 on a prolonged course of
oral antibiotics.
Discussion
Prosthetic graft infection is a devastating outcome of
aortoiliac revascularization procedures. It complicates
0.5–3.5% of patients [4, 5], and has a mortality rate as
high as 75% [6, 7]. Definitive management is graft exci-
sion with subsequent revascularization either by extra-
anatomical or in situ reconstruction. In clinical practice,
however, treatment is tailored according to patient
comorbidities and the Samson’s modified Szilagyi classifi-
cation system of extracavitary vascular graft infection is
useful (a system which correlates extent of infection with
prognosis) [7, 8]. Challenges arise when managing axillo-
femoral graft infections when they occur in patients who
have few revascularization options and are unable to tol-
erate major reoperative procedures. In such cases, the
most appropriate treatment option may actually be graft
salvage or conservative management with antibiotics
rather than graft excision [7, 8]. In the context of overt
sepsis with hemodynamic compromise, an infected vascu-
lar graft which has eroded through adjacent structures
mandates graft removal.
In our case, further revascularization upon graft
removal initially appeared inevitable given that it was the
only source of perfusion to the right lower limb. Cross-
clamping a patent vascular graft with clinical assessment
of limb viability is a useful and simple technique which
can be used to predict the need for a revascularization
procedure following removal of an infected graft. This
allows the surgeon to better plan or avoid a prolonged
open aortic procedure and its associated morbidity and
mortality in surgically high risk patients.
An array of therapeutic options for graft infections have
been described in the literature. Evolution of minimally
invasive techniques has allowed many procedures histori-
cally preformed under general anesthesia to be performed
more conservatively under local and spinal anesthesia. This
has provided an alternate limb salvage option for elderly
patients where endovascular recanalization is anatomically
not feasible or their cardiorespiratory fitness is of concern.
Al-Wahbi [9] reported the successful revascularization of
an ischemia foot in an octogenarian with an axillofemoral
bypass graft under local anesthesia. Cappello et al [6].
reported 100% success rate in limb revascularization at
30 days when spinal and local anesthesia were used to gain
femoral and axillary access, respectively, in constructing an
axillofemoral bypass. Such surgical advancement has
reduced patient mortality and morbidity compared to ear-
lier results. A retrospective study of infected axillofemoral
grafts presenting to a university hospital from 1982 to 1993
reported 57% of survivors resulted in having a limb ampu-
tation [10]. Had our patient required a further revascular-
ization procedure then the option of a left axillofemoral
Figure 1. Externalized section of the axillofemoral bypass graft.
Figure 2. 3D reconstructed CT Angiography: The axillofemoral graft
extends from proximal to the axillary artery to the common femoral
artery, descending superficial to the thoracic cage.
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bypass under local anesthesia would have been the next
step.
Restoring lower extremity perfusion following axillofe-
moral graft excision with endovascular reconstruction has
too been reported in the literature [11]. There is hesitancy
from surgeons to replace extra-anatomical and endovascu-
lar grafts in an infected field due to the risk of local recur-
rence. Prompt administration of empirical antibiotics and
debridement of tissue within the perigraft area will help to
reduce bacterial colonization. Staphylococcus is the pre-
dominant microorganism cultured. Colonization with non-
coagulase-negative staphylococcus correlates with late
infections. Proteus mirabils and other gram negative organ-
isms are associated with high rupture and anastomotic fail-
ure rates [12]. As seen in our case, empirical antibiotic
treatment with anaerobic coverage should therefore be
promptly administered to improve patient outcomes.
Conclusion
In summary, explantation of an infected patent vascular
graft does not necessarily require concomitant revascular-
ization procedures. The need for revascularization can be
determined by a trial cross-clamping of the graft and clin-
ical assessment of limb perfusion. Our report of an
infected axillofemoral graft which has transgressed the
chest wall contributes to the limited literature on manag-
ing extra-anatomical graft infections in surgically high
risk patients. An understanding of the management of
prosthetic vascular graft infections is of equal importance
to nonvascular surgeons as it is to vascular surgeons.
Though it is rare, graft infections are associated with
significant mortality and morbidity.
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